Edition:
India

Nichi-Iko Pharmaceutical Co Ltd (4541.T)

4541.T on Tokyo Stock Exchange

1,679JPY
11:30am IST
Change (% chg)

¥-6 (-0.36%)
Prev Close
¥1,685
Open
¥1,690
Day's High
¥1,696
Day's Low
¥1,675
Volume
145,600
Avg. Vol
323,846
52-wk High
¥1,801
52-wk Low
¥1,570

Latest Key Developments (Source: Significant Developments)

Nichi-Iko Pharmaceutical to start sales of Infliximab BS for I.V. Infusion 100mg "Nichi-Iko"
Tuesday, 28 Nov 2017 

Nov 28 (Reuters) - Nichi-Iko Pharmaceutical Co Ltd <4541.T>:Says it will start sales of Infliximab BS for I.V. Infusion 100mg "Nichi-Iko" on Nov. 29.  Full Article

Nichi-Iko Pharmaceutical fully buys Sagent Pharmaceuticals, Inc. via takeover bid
Monday, 29 Aug 2016 

Nichi-Iko Pharmaceutical Co Ltd <4541.T>:Says it completed full acquisition of Sagent Pharmaceuticals, Inc. via takeover bid, effective Aug. 29(the U.S. time).  Full Article

Shepard Vision commences all-cash tender offer of $21.75 net per share to buy shares of Sagent
Monday, 1 Aug 2016 

Shepard Vision Inc:Commences all-cash tender offer of $21.75 net per share to acquire all outstanding shares of Sagent Pharmaceuticals, Inc.  Full Article

Sagent Pharma will be required to pay Nichi-Iko Pharma $24.3 mln upon termination of deal
Monday, 11 Jul 2016 

Sagent Pharmaceuticals Inc :Upon termination of deal, under specified circumstances, co will be required to pay Nichi-Iko Pharma termination fee of $24.3 million.  Full Article

Japan's Nichi-Iko to buy Sagent Pharmaceuticals for $21.75 per share in cash
Monday, 11 Jul 2016 

Sagent Pharmaceuticals Inc : Nichi-Iko pharmaceutical Co, Ltd to acquire Sagent Pharmaceuticals for $21.75 per share in all cash transaction . Deal for approximately $736 million . Nichi-Iko intends to finance acquisition through bank loans and available cash .Transaction unanimously approved by Nichi-Iko and Sagent boards of directors.  Full Article